NCT04579757 2025-05-08Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid TumorsHutchmedPhase 1/2 Terminated87 enrolled 29 charts
NCT03154190 2025-01-24Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerStanford UniversityPhase NA Completed128 enrolled 24 charts
NCT00780494 2025-01-14Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric CarcinomaStanford UniversityPhase 2 Completed35 enrolled 13 charts
NCT03474640 2024-11-22Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced MalignanciesTopAlliance BiosciencesPhase 1 Completed184 enrolled 20 charts
NCT01034670 2024-06-26Advanced Gastrointestinal Endoscopic ImagingStanford UniversityPhase NA Terminated3 enrolled 6 charts
NCT03525392 2023-12-12Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.IpsenPhase 1 Terminated14 enrolled 20 charts
NCT01275222 2021-06-25Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal TumorsNovartisPhase 1/2 Completed117 enrolled 18 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts